SOPHiA GENETICS share price logo

SOPHiA GENETICS

NASDAQ: SOPH

Small Cap

$7.21

-0.20

(-2.70%)

as on

SOPHiA GENETICS Stock Performance

as on October 13, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $7.13
    $7.69
    downward going graph

    1.11%

    Downside

    6.66%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.75
    $8.98
    downward going graph

    47.99%

    Downside

    24.55%

    Upside

    downward going graph

SOPHiA GENETICS share price movements today

Previous Close
$7.41
Open
$7.62
Volume
527.4K
Market Cap
$630.8M
Day's Low - High
$7.13 - $7.69
52 Week Low - High
$3.75 - $8.98

SOPHiA GENETICS Historical Returns

1 Month Return
-5.84 %
3 Month Return
+ 31.15 %
1 Year Return
+ 77.27 %
3 Year Return
+ 146.18 %
5 Year Return
-52.98 %

SOPHiA GENETICS Stock Fundamentals & Key Indicators

Check SOPHiA GENETICS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$630.8M

EPS (TTM)

-1.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.44

Industry PE ratio

0.29

PEG Ratio

1.39

EBITDA

-63.8M

Revenue (TTM)

86.2M

Profit Margin

66.63%

Return On Equity TTM

-136.71%

SOPHiA GENETICS vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SOPHiA GENETICS with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SOPHiA GENETICS image
SOPHiA GENETICS
StrongBuy$630.8M-52.98%-6.4466.63%0.00%
Veeva Systems image
Veeva Systems
Buy$47.9B3.54%47.6974.96%0.00%
Hinge Health, Inc. Class A image
Hinge Health, Inc. Class A
StrongBuy$7.9BNA72.7884.52%0.00%
Tempus AI, Inc. Class A image
Tempus AI, Inc. Class A
Buy$12.8BNA-49.6063.98%0.00%
BrightSpring Health Services, Inc. image
BrightSpring Health Services, Inc.
StrongBuy$12.6BNA44.5712.38%0.00%

Stock Returns calculator for SOPHiA GENETICS Stock including INR - Dollar returns

The SOPHiA GENETICS stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

SOPHiA GENETICS investment value today

Current value as on today

₹1,86,291

Returns

₹86,291

(+86.29%)

Returns from SOPHiA GENETICS Stock

₹72,488 (+72.49%)

Dollar Impact

₹13,803 (+13.8%)

Analyst Recommendation on SOPHiA GENETICS Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for SOPHiA GENETICS. Average target price of $9.75

SOPHiA GENETICS Share Price Target

Get share price movements and forecasts by analysts on SOPHiA GENETICS.

What analysts predicted

26.05%UPSIDE

Target Price

$9.75

Current Price

$7.21

Analyzed by

4 Analysts

High

$14

Target

$9.75

Low

$9

SOPHiA GENETICS target price $9.75, a slight upside of 26.05% compared to current price of $7.21. According to 4 analysts rating.

Indian Investors' Interest in SOPHiA GENETICS Stock

Search interest for SOPHiA GENETICS Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

SOPHiA GENETICS Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
15
15
15
17
17
18
19
21
21
23
Gross Profit
10
10
10
12
12
12
12
14
14
15
Operating Income
-18
-15
-15
-17
-16
-18
-17
-18
-17
-20
EBITDA
-11
-12
-16
-7
-13
-18
-15
-15
-14
-17
Interest Expense
0
0
-
-
0
0
1
1
1
1
Depreciation
2
2
2
2
2
2
2
2
2
2
Income Before Tax
-13
-15
-18
-14
-16
-21
-19
-19
-19
-22
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-13
-15
-18
-15
-17
-22
-20
-19
-19
-22
Net Profit Margin
65.94%
68.17%
67.20%
68.25%
68.67%
66.97%
66.32%
67.68%
68.01%
64.61%

SOPHiA GENETICS Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
25
28
40
47
62
65
77
Gross Profit
17
17
25
31
42
43
47
Operating Income
-32
-37
-71
-87
-74
-66
-70
EBITDA
-30
-37
-69
-81
-69
-50
-64
Interest Expense
0
0
0
0
0
1
4
Depreciation
1
2
3
5
8
8
9
Income Before Tax
-33
-41
-73
-87
-78
-61
-78
Income Tax Expense
0
-1
0
0
0
1
0
Net Income
-33
-39
-73
-87
-78
-62
-78
Net Profit Margin
70.30%
62.29%
62.35%
65.71%
68.80%
67.42%
61.88%

SOPHiA GENETICS Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-13
-15
-18
-14
-16
-21
-20
-19
-19
-22
Operating Cash Flow
-14
-10
-7
-10
-10
-8
-8
-8
-16
-7
Investing Cash Flow
-1
-1
-4
-1
-1
-1
-2
-3
-2
-2
Financing Cash Flow
0
12
0
0
0
33
-1
0
14
53
Change in Cash
-19
1
-9
-15
-11
26
-13
-11
-4
42

SOPHiA GENETICS Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-41
-73
-87
-78
-61
-78
Operating Cash Flow
-31
-31
-57
-70
-48
-42
-38
Investing Cash Flow
-3
-24
-56
41
8
-8
-10
Financing Cash Flow
-1
107
237
-1
-2
11
34
Change in Cash
-35
56
118
-31
-38
-43
-9

Global Institutional Holdings in SOPHiA GENETICS

Check out the Institutions with significant holdings in SOPHiA GENETICS.

Funds
Holdings
David Blood
7.98%
Chuck Akre
4.37%
Chuck Royce
3.97%
ROYCE FUND
0.92%
Principal Funds, Inc
0.74%
See all

SOPHiA GENETICS News & Key Events

  • img

    Today's Timeline - 08 October

    Thu, 06:35 PM

    -

    Myriad Genetics and Sophia Genetics collaborate on prostate cancer genomic instability score technology to enhance precision oncology with AstraZeneca.

Insights on SOPHiA GENETICS

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 21.68M → 23.31M (in $), with an average increase of 7.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SOPH has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BrightSpring Health Services, Inc. Common Stock has given 124.8% return, outperforming this stock by 47.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -19.17M → -22.35M (in $), with an average decrease of 8.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SOPH stock has moved down by -9.6%

About SOPHiA GENETICS

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
OrganisationSOPHiA GENETICS
HeadquartersLa Piece 12, Rolle, VD, 1180, CH
IndustryMedical - Healthcare Information Services
CEORoss Muken

Key Management of SOPHiA GENETICS

Name

Title

Dr. Jurgi Camblong M.B.A., Ph.D.

Co-Founder & Executive Chairman

Mr. Ross Jordan Muken B.Sc.

CEO & Director

Mr. Abhimanyu Verma

EVP & Chief Technology Officer

Mr. Daan van Well L.L.M., M.B.A.

Executive VP and Chief Legal & Compliance Officer

Ms. Manuela Da Silva Valente B.A.

Executive VP & Chief People Officer

Dr. Philippe Menu M.B.A., M.D., Ph.D.

Executive VP, Chief Medical Officer & Chief Product Officer

Mr. George A. Cardoza M.B.A.

Executive VP & CFO

Dr. Zhenyu Xu Ph.D.

Executive VP & Chief Scientific Officer

Kellen Sanger

Head of Strategy and Investor Relations

Mr. Kevin Puylaert

SVP & Chief Sales Officer

FAQs

What is SOPHiA GENETICS share price today?

SOPHiA GENETICS share price today is $7.21 as on at the close of the market. SOPHiA GENETICS share today touched a day high of $7.69 and a low of $7.13.

What is the 52 week high and 52 week low for SOPHiA GENETICS share?

SOPHiA GENETICS share touched a 52 week high of $8.98 on and a 52 week low of $3.75 on . SOPHiA GENETICS stock price today i.e. is closed at $7.21,which is 19.71% down from its 52 week high and 92.27% up from its 52 week low.

What is SOPHiA GENETICS's market capitalisation today?

SOPHiA GENETICS market capitalisation is $0.00T as on .

How to invest in SOPHiA GENETICS Stock (SOPH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for SOPHiA GENETICS on INDmoney app. Click on Buy button.

What is the minimum amount required to buy SOPHiA GENETICS Stock (SOPH) from India?

Indian investors can start investing in SOPHiA GENETICS (SOPH) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in SOPHiA GENETICS stock (as per the Rupee-Dollar exchange rate as on ). Based on SOPHiA GENETICS share’s latest price of $7.21 as on October 13, 2026 at 1:29 am IST, you will get 1.3870 shares of SOPHiA GENETICS. Learn more about fractional shares .

What are the returns that SOPHiA GENETICS has given to Indian investors in the last 5 years?

SOPHiA GENETICS stock has given -52.98% share price returns and 28.2% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?